Cited by

• Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.

  Wang L, Cai Y, Jian L, Cheung CW, Zhang L, Xia Z. Wang L, et al. Cardiovasc Diabetol. 2021 Jan 4;20(1):2. doi: 10.1186/s12933-020-01188-0. Cardiovasc Diabetol. 2021. PMID: 33397369 Free PMC article. Review.
• Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy.

  Jinnouchi H, Morita K, Tanaka T, Kajiwara A, Kawata Y, Oniki K, Saruwatari J, Nakagawa K, Otake K, Ogata Y, Yoshida A, Hokimoto S, Ogawa H. Jinnouchi H, et al. Cardiovasc Diabetol. 2015 May 8;14:49. doi: 10.1186/s12933-015-0212-5. Cardiovasc Diabetol. 2015. PMID: 25952030 Free PMC article.
• Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

  Kim NH, Lee J, Chon S, Yu JM, Jeong IK, Lim S, Kim WJ, Song K, Cho HC, Yu HM, Kim KA, Kim SS, Lee SH, Kim CH, Kwak SH, Lee YH, Chung CH, Lee S, Jin HY, Lee JH, Koh G, Kim SY, Kim J, Lee JH, Kim TN, Jeon HJ, Lee JH, Jeon JH, Yoo HJ, Kim HK, Park HK, Nam-Goong IS, Hong S, Ahn CW, Yu JH, Park JH, Park KG, Park CH, Joung KH, Ryu OH, Park KY, Hong EG, Cha BS, Won KC, Chung YS, Kim SG. Kim NH, et al. Endocrinol Metab (Seoul). 2024 Oct;39(5):722-731. doi: 10.3803/EnM.2024.1995. Epub 2024 Aug 22. Endocrinol Metab (Seoul). 2024. PMID: 39174014 Free PMC article.
• Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients.

  Shetty SR, Kumar S, Mathur RP, Sharma KH, Jaiswal AD. Shetty SR, et al. Indian Heart J. 2015 Jan-Feb;67(1):23-6. doi: 10.1016/j.ihj.2015.02.007. Epub 2015 Feb 26. Indian Heart J. 2015. PMID: 25820046 Free PMC article.
• Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review.

  Velidakis N, Stachteas P, Gkougkoudi E, Papadopoulos C, Kadoglou NPE. Velidakis N, et al. Pharmaceuticals (Basel). 2024 Apr 29;17(5):568. doi: 10.3390/ph17050568. Pharmaceuticals (Basel). 2024. PMID: 38794138 Free PMC article. Review.